While these findings collectively suggest that α-synuclein aggregates may be present in the ENS at early PD stages, consistent with a peripheral initiation of pathology, it is not possible to confirm a specific sequential progression of α-synuclein disease from postmortem (endpoint-only) studies. Here, SNCA is linked to Parkinson disease.